glp 1 drugs injection How GLP-1 medications are transforming diabetes and weight loss treatment List of approved and pending

doi: 10.1055/s-0043-109563

After being presented with these arguments, the publics attitudes remain largely unchanged, with six in ten adults still saying they think Medicare should cover the cost of these drugs when prescribed for weight loss for people who are overweight

A stronger effect may also bring stronger side effects

Key Takeaways Diarrhea is a common gastrointestinal side effect of semaglutide, especially as the medication alters how quickly food moves through the digestive system

The FDAs action also opened a door for Medicare coverage in patients with cardiovascular disease an early sign that access for these expensive medicines could expand beyond the well-insured

For real-world users, studies show that, after one year, participants taking Semaglutide lost 7.7% of their body weight, and participants taking tirzepatide lost 12.4% of their body weight